Retinal Vascular Disease Agents |
Beovu (brolucizumab), Eylea (aflibercept), Eylea HD (aflibercept), Lucentis 0.3 mg (ranibizumab), Cimerli 0.3mg (ranibizumab-eqrn), Lucentis 0.5mg (ranibizumab), Byooviz (ranibizumab-nuna), Cimerli 0.5mg (ranibizumab-eqrn), Pavblu (aflibercept-ayyh), Susvimo (ranibizumab), Vabysmo (faricimab-svoa) |
Revcovi (elapegademase-IvIr) |
Revcovi (elapegademase-IvIr) |
Revlimid (lenalidomide) |
Revlimid (lenalidomide) |
Revuforj (revumenib) |
Revuforj (revumenib) |
Reyvow (lasmiditan) - PA, NF |
Reyvow (lasmiditan) |
Rezdiffra (resmetirom) - PA, NF |
Rezdiffra (resmetirom) |
Rezlidhia (olutasidenib) - PA, NF |
Rezlidhia (olutasidenib) |
Rezurock (belumosudil) - PA, NF |
Rezurock (belumosudil) |
Rezzayo (rezafungin) |
Rezzayo (rezafungin) |
Riluzole Products - PA, NF |
Exservan (riluzole film), Rilutek (riluzole tablets), Tiglutik (riluzole suspension), Teglutik (riluzole suspension) |
Rinvoq (upadacitinib) |
Rinvoq (upadacitinib) ER tablets, Rinvoq LQ (upadacitinib) oral solution, Rinvoq (upadacitinib) extended-release (ER) tablets |
Rituxan Hycela (rituximab and hyaluronidase human) |
Rituxan Hycela (rituximab and hyaluronidase human) |
Rituximab - PA, NF |
Riabni (rituximab-arrx), Rituxan (rituximab), Ruxience (rituximab-pvvr), Truxima (rituximab-abbs) |
Rivfloza (nedosiran) |
Rivfloza (nedosiran) |
Roctavian (valoctocogene roxaparvovec-rvox) |
Roctavian (valoctocogene roxaparvovec-rvox) |
Roszet (rosuvastatin/ezetimibe) - ST, NF |
Roszet (rosuvastatin/ezetimibe) |
Rozlytrek (entrectinib) |
Rozlytrek (entrectinib) |
Rubraca (rucaparib) - PA, NF |
Rubraca (rucaparib) |
Rybrevant (amivantamab) |
Rybrevant (amivantamab) |
Rydapt (midostaurin) |
Rydapt (midostaurin) capsules |